• Latest Posts

Sanofi and Innate Pharma expand natural killer cell deal

BMS’s Cancer Trial Showcases Potential for Checkpoint Inhibitors

In Depth 6 Jul 2020

How Immuno-Oncology Contributes to the Fight Against Covid-19

More News! 17 Oct 2019

Sofinnova Partners Raises €333M for its Newest Life Sciences-Focused Fund

Innate Pharma Raises €62M IPO to Develop Antibody Drugs for Cancer

Innate’s Cancer Immunotherapy Combo Beats Standard Treatment Twofold


Two Biotechs Team Up to Test their Cancer Antibody Combo in the Clinic

Grab the Tissues: Here are the 8 Biggest European Biotech Clinical Failures of 2017

French Biotech Strikes Deal with Novo Nordisk for New Cancer Drug

How is Biotech Transforming Pharma’s R&D Model?

Infographics 13 Feb 2017

Infographic: What’s in Europe’s Immuno-oncology Pipeline?

French Biotech’s Checkpoint Inhibitor Fails Phase II Leukemia Trial